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In search of novel gene signatures for osteo-differentiation of mesenchymal stem cells (MSCs), we
submitted cDNA preparations from undifferentiated and differentiating MSCs to differential display- and
semiquantitative-PCR and found down-regulation of COL5A1 in osteo-induced cultures at days 21 and 28,
when the mineralized matrix accumulates. We also cultured osteo-differentiating MSCs onto type V
collagen substrates and found a decrease in the accumulation of extracellular calcium compared to those
grown in uncoated ﬂasks. To our knowledge, this is ﬁrst evidence that type V collagen might represent a
stromal component that impairs osteogenesis.
© 2014 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Human fat tissue represents a valid alternative source of
mesenchymal stem cells (MSCs) to bone marrow (BM), which al-
lows obtaining an in vitro model system of primary cultures con-
taining the stem cell population present in situ. Furthermore,
liposuction samples permit the isolation of a 500 times higher
number of cells as compared to BM-derived MSCs, avoiding addi-
tional pain and discomfort for the patient, without major ethical
limitations for their use. The multipotentiality of MSCs from adi-
pose tissue, coupled to their self-renewability, is closely linked to
their therapeutic interest, in that these cells might ﬁnd utilization
in cell therapy and tissue engineering, being easily addressed
in vitro to differentiate into diverse cytotypes, including osteoblasts
(e.g. Refs. [1,2]). Although the differentiation of fat tissue-derived
MSCs into various lineages are standard procedures, the precise
molecular mechanisms involved are still poorly understood, mak-
ing the study of the differentiation pathways of these cells of basic, bone marrow; PCR, poly-
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because the transient utilisation of such pathways may allow the
ampliﬁcation of stem cells in culture which represents a current
challenge in most cell-based therapies and in the ﬁeld of regener-
ative medicine. In addition, it is necessary to have a more detailed
knowledge of the differentiation event to determine the impact of
new molecules on the process of tissue formation. Here we report
that type V collagen might be considered as a negative stromal
modulator of MSC osteogenesis.2. Materials and methods
2.1. Cell cultures, collagen substrate and differentiation
LW28, LW36 and LW40 MSC cultures, isolated from adipose
tissue samples obtained by liposuction of three female patients,
respectively 28, 36 and 40 years old, were differentiated at passage
5 towards osteoblast lineage, and the differentiation checked as
already shown by Longo et al. [3].
Type V collagen substrate (Sigma) was prepared as reported in
Ref. [4]. MSCs were plated at a concentration of 2  104 cells/cm2
with the osteogenic differentiation medium in plain and
collagen-coated dishes. The media were carefully changed once a
week. After four weeks, osteogenic differentiation was visualized
by staining of extracellular calcium deposits with Alizarin Red S
[3].y Elsevier Ltd. All rights reserved.
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Total RNA was obtained with Tri Reagent (Sigma) and enriched
mRNA fractions with Terminator™ 50-Phosphate-Dependent
Exonuclease (Epicentre, Madison, WI/USA). The cDNAs were syn-
thesized using SuperScript II reverse transcriptase (Invitrogen) as
reported in Ref. [3].2.3. Differential display (DD)- and semiquantitative PCR
DD-PCR experiments were performed using the arbitrary 10-
mer primers designed by Sokolov and Prockop [5], as reported in
Refs. [6,7]. The PCR products were analyzed with 6% non-
denaturing PAGE in a sequencing apparatus followed by silver
staining. A 50 bp ladder (Invitrogen) was used as a size marker.Fig. 1. Identiﬁcation of COL5A1 as an undifferentiated MSC-related expression and effect of t
PCR (DD-PCR) of cDNA preparations from undifferentiated (U) and osteo-differentiating (O)
gel. The arrow points to a band of about 150 bp selectively present in cDNA preparations from
semiquantitative “multiplex” PCR for COL5A1. The histograms summarize the results from t
differentiating (grey box) LW28 and LW40 MSCs at days 21 and 28 of culture, demonstrating
and LW40 MSCs induced to osteogenic differentiation in the presence (þ) or absence () of t
of the histochemical staining in the presence of type V collagen substrate, indicative of an im
the references to colour in this ﬁgure legend, the reader is referred to the web version of t
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cDNA and the relative difference in abundance between the
experimental conditions evaluated as reported in Ref. [8].3. Results and discussion
In order to expand the list of gene signatures associated with
osteo-induction of MSCs, enriched mRNA samples isolated from
undifferentiated and differentiating LW36 cell preparations at day
7, 14, 21 and 28 of culture were reverse transcribed and submitted
to differential display-PCR (DD-PCR), and the ampliﬁcation prod-
ucts electrophoresized and visualized by silver stain. Among the
different products present in the gel, we focused our interest on an
ampliﬁcation band of approximately 150 bp (Fig. 1A) selectively
absent in the cDNA preparation of MSCs at the third week ofype V collagen substrate on the extent of osteo-differentiation. (A) Differential display-
LW36 MSCs. The image shows the enlargement of a portion of a silver-stained 6% PAGE
undifferentiated MSCs and ampliﬁed with primers BS76 and BS78. (B) Representative
he assays on cDNA preparations obtained from undifferentiated (black box) and osteo-
a decrease of COL5A1 gene following osteo-induction. (C) Alizarin red staining of LW28
ype V collagen substrate at day 28 of culture. The micrographs show a drastic reduction
pairment of the process of osteo-differentiation. (Bar ¼ 10 mm). (For interpretation of
his article.)
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visible by Alizarine Red histochemical staining of calcium-rich de-
posits [4]. The cDNA contained in the band was puriﬁed by excision
from the gel, re-ampliﬁed until purity and adequate yield, and then
the material was submitted to sequencing. Homology was found in
the online databases between the sequence obtained and that of
region 5491e5635 of the coding sequence for a1 chain of type V
collagen (COL5A1, gene id: 1289 COL5A1; score: 455 bits, expect:
5e-126, identities 100%, gap 0%). Interestingly, the analysis by
FASTA also showed homology with region 5491e5635 of a patented
sequence called “stem cell speciﬁc marker” (acc. nr. DM149324; Z-
score: 1176.1, bits: 230.2, expect: 1.4e-56, identity 100%, gap 0%).
For semi-quantitative evaluation in more stringent conditions than
DD-PCR and to investigate whether the differential expression was
also present in the cell cultures obtained from the other donors, the
cDNA preparations from either undifferentiated and differentiating
LW28 or LW40 cells at days 21 and 28 of culture were submitted to
conventional and multiplex PCR analysis in the presence of COL5A1
speciﬁc primers [9], and amplifying the housekeeping gene 18S in
parallel. The obtained results showed that an ampliﬁcation signal
for COL5A1was present in all experimental conditions (not shown),
but in osteo-induced cells the COL5А1 expression level was down-
regulated compared to undifferentiated stem cells, to about 50%
and 31.5% (for LW28 cells) and 57% and 30% (for LW40 cells) at days
21 and 28 of culture, respectively, that is when the mineralized
matrix accumulates (Fig. 1B). No difference of COL5A1 expression
level could be observed between stem and differentiating cells at
days 7 and 14 of culture (not shown). No attempt was made to
quantify the produced type V collagen in the different experimental
conditions.
Secondly, assuming that the down-regulation of COL5A1 might
be essential to the acquisition of a mature osteogenic phenotype by
differentiating cells, ﬂasks covered with bi-dimensional type V
collagen ﬁlms were prepared to investigate whether this collagen,
used as a substrate for MSC cultures submitted to exposition to
osteogenic inducers, could restrain the differentiation process, due
to the continuous and prolonged adhesion of MSCs. Osteogenesis
was monitored through the deposition of extracellular calcium by
Alizarin Red staining. The data obtained at the fourth week of dif-
ferentiation showed a drastic decrease in the accumulation of
extracellular calcium by LW28 and LW40 cells, compared to the
counterparts induced to differentiation in the absence of type V
collagen substrate (Fig. 1C).
It is generally acknowledged that the extracellular matrix (ECM)
is not to be regarded as a mere passive scaffold for connective tis-
sues within organ architecture, but that cell-ECM interactions may
inﬂuence a number of biological activities. Collagen, the major
constituents of connective tissues, is a protein family composed of
at least 28 genetically-distinct species, grouped in different cate-
gories, originating from the coiling of three polypeptides of about
1000 aminoacids called a-chains. The a-chain composition of the
different collagens can give rise to either homo- or heterotrimeric
types that accumulate in the ECM, thereby interacting with other
micro-environmental components as well as cell receptors, thereby
exerting a prominent feedback effect on the control of cell
phenotypic expression [10]. Type V collagen, which belongs to the
category of the ﬁbril-forming collagens and may be assembled as
[a1(V)]2a2(V), a1(V)3 and a1(V)a2(V)a3(V) variants, is a minor
component of the stroma which can be predominantly found in
pericellular areas [11,12]. The cellular responses elicited by this
collagen species appear heterogeneous, suggesting differences
among the model systems examined (e.g. tissue and cell types). For
example, adhesion- and motility-promoting activity has been
observed for glomerular endothelial cells, Schwann cells, and os-
teosarcoma cells [13e15]. On the other hand, anti-adhesive, anti-Please cite this article in press as: Longo A, et al., Type V collagen co
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cytotypes such as ﬁbroblasts, colorectal adenocarcinoma cells, and
lung epithelial cells [16e18]. In addition, a putative “anti-cancer”
activity has been foundwhen used as a substrate for 8701-BC breast
cancer cells, determining slow-down of growth rate, inhibition of
motility and invasion in vitro, loss of membrane integrity, oligo-
nucleosomal DNA fragmentation, changes in the expression levels
of genes coding for apoptosis-linked factors, calpain, caspases and
stress response proteins, and enhancement of caspase enzymatic
activity [4,8,19e21]. The data reported here expand the list of the
recognized cellular effects of type V collagen, being, to our
knowledge, the ﬁrst evidence that this collagen species, whose a1
chain is encoded by a gene that in the databases is also deﬁned
“stem cell marker”, might represent a component of the extracel-
lular matrix that counteracts the effect of osteogenic factors on
MSCs. Interestingly, Fawzy El-Sayed and co-workers [22] reported
that STRO-1-expressing multipotent postnatal stem/progenitor
cells [23] isolated from human alveolar bone displayed a
signiﬁcantly-higher expression of mineralized tissue markers,
including type V collagen, with respect to periodontal osteoblasts
extracted from the same source.
4. Conclusions
In conclusion, our results expand the list of the micro-
environmental components controlling the process of bone for-
mation and prompt the setting up of future experiments aimed to
investigate more in detail the cellular and molecular aspects of the
inhibitory effect shown by type V collagen substrate on osteo-
differentiation of MSCs, thereby extending the knowledge about
the intracellular processes that impair the differentiation event.
Technical-scientiﬁc advances in the areas of cellular and molecular
biology, facilitated by studies about human somatic stem cells, may
positively inﬂuence the advance of clinical research with MSCs. The
knowledge of the basic mechanisms of differentiation may thus
help the development of new therapies and the evaluation of bio-
security issues in future clinical protocols.
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